Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL

Detalles Bibliográficos
Autores principales: He, Xiaoyuan, Xiao, Xia, Li, Qing, Jiang, Yanyu, Cao, Yaqing, Sun, Rui, Jin, Xin, Yuan, Ting, Meng, Juanxia, Ma, Li, Lu, Wenyi, Lyu, Cuicui, Liu, Kaiqi, Zhao, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756216/
https://www.ncbi.nlm.nih.gov/pubmed/30846865
http://dx.doi.org/10.1038/s41375-019-0437-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756216/
https://www.ncbi.nlm.nih.gov/pubmed/30846865
http://dx.doi.org/10.1038/s41375-019-0437-5

Ejemplares similares